Corona and Parley for the Oceans partner with Stephanie Gilmore, Gabriel Medina and artists to support the ban of single-use plastic in Bali and provide households with reusable alternatives.
14.5.2019 10:00:00 EEST | Business Wire | Press release
It is estimated that roughly 5 trillion plastic bags are consumed worldwide each year1 with as many as 10 million plastic bags entering circulation in Indonesia every day2. Earlier this year, Bali announced a ban of all single-use plastic (including plastic bags) that takes affect later this year. For the first time, Balinese would have to rely on reusable bags exclusively.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190514005361/en/
Corona's La Casa pop-up space, made from 1.5 tons of recycled plastic. (Photo: Business Wire)
To help support the local NGOs who have been leading the charge against single-use plastic and as part of their commitment to the region where the annual Bali Pro-tected surf event takes place, Corona, Parley and World Surf League are donating 20,000 reusable bags made from Ocean Plastic®. Limited edition bags are also being created on-site and will be sold in real-time at wslstore.com. The proceeds from each bag purchased funds the donation of an additional 3 bags to the local community and the removal of more than 20 bottles worth of plastic. The ambition over time is to provide one bag for every household in Indonesia.
The limited-edition bags were designed by Stephanie Gilmore, Gabriel Medina and Rosy Hodge in partnership with artists Nadia Hernandez, Speto and Gemma O’Brien respectively. Surfers on the WSL Championship Tour have also shown their support by designing their own bags to raise awareness of the project. The collaborators are part of the inaugural “La Casa” pop-up, a house made from 1.5 tons of recycled plastic in partnership with NevHouse. Founded by Corona, the house will become a platform for surfers, artists and thought-leaders to work on projects that can inspire a better world. The house itself is a positive reminder that plastic can be given a meaningful second life, much like the bags. Each pop-up will include new collaborators and new projects to help protect paradise from plastic pollution.
“The La Casa platform is about collaboration and creativity to energize the fight against marine plastic pollution,” said Evan Ellman, Corona Better World Director. “In this case, Corona and our partners Parley and World Surf League, were inspired by the movement to ban single-use plastic in Bali and recognized an opportunity to support the transition. Just as impressive are the talented collaborators who signed on to bring their voice and point of view to the project. The result is a product that is not only a symbol of change, but also has a significant impact on the environment and community.”
La Casa is the latest initiative from Corona and Parley for the Oceans who have a mutual mission to protect the world’s oceans and beaches. To date, the partnership has engaged in 100 islands around the world through a clean-up network present in over 23 countries, resulting in 537 clean-ups, 25,000 volunteers and more than 3 million square meters of beach cleaned. This includes Corona’s support of Parley’s strategy to end marine plastic pollution: A.I.R. (Avoid, Intercept and Redesign). Most recently, Corona and Parley partnered with Oscar-nominated stop-motion artist PES to create a film on Earth Day raising awareness that “avoiding” and “intercepting” plastic saves the lives of marine wildlife. The La Casa initiative in Bali is an example of how that plastic can be “redesigned” into a product that replaces single-use plastic.
La Casa Corona will be at the Corona Bali Pro-tected event in Keramas, Bali, Indonesia from May 13 - May 25, 2019. To learn more and purchase a bag visit wslstore.com.
-###-
ABOUT CORONA
Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City. Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage. No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life.
ABOUT PARLEY FOR THE OCEANS
Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), American Express; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv
ABOUT THE WSL
The World Surf League (WSL) is the global home of surfing, dedicated to celebrating the world's best surfing on the world's best waves. The WSL has been championing the world's best surfing since 1976, annually running more than 180 global events across the Men's and Women's Championship Tours, the Big Wave Tour, the Longboard Tour, Qualifying Series, Pro Junior Tour, as well as the WSL Big Wave Awards. The League possesses a deep appreciation for the sport's rich heritage while promoting progression, innovation, and performance at the highest levels, and in doing so crowns the undisputed Men’s and Women’s World Champions across all tours. For more information, please visit WorldSurfLeague.com.
1
https://wedocs.unep.org/bitstream/handle/20.500.11822/25513/state_plastics_WED.pdf?isAllowed=y&sequence=1
2
https://www.theinertia.com/environment/indonesia-pledges-1-billion-a-year-to-reduce-its-ocean-waste/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190514005361/en/
Contact information
Alison Brod Marketing + Communications:
Corona@alisonbrodmc.com
212-230-1800
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom